Telomerase activity in myelodysplastic syndromes

Leukemia Research

Volumn 29, Issue 10, 2005, Pages 1131-1139

  Gürkan, Emel ^a   Tanriverdi, Kahraman ^a   Başlamişli, Fikri ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Myelodysplastic syndrome; Prognosis; Telomerase activity

Indexed keywords

TELOMERASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANEMIA; ARTICLE; BLOOD SAMPLING; BONE MARROW; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DYNAMICS; ENZYME ACTIVITY; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; POLYMERASE CHAIN REACTION; SURVIVAL RATE; TELOMERASE;

EID: 23844518020     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.03.006     Document Type: Article

References (23)

1. E.H. Blackburn Structure and function of telomeres Nature 350 1991 569 573
2. M. Engelhardt, R. Kumar, J. Albanell, R. Pettengell, W. Han, and M.A. Moore Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells Blood 90 1997 182 193
3. K. Ohyashiki, and J.H. Ohyashiki Telomere dynamics and cytogenetic changes in human hematologic neoplasias: a working hypothesis Cancer Genet Cytogenet 94 1997 67 72
4. O. Bock, E. Serinsoz, J. Schlue, and H. Kreipe Different expression levels of the telomerase catalytic subunit hTERT in myeloproliferative and myelodysplastic diseases Leuk Res 28 2004 457 460
5. Z. Sieglova, S. Zilovcova, J. Cermak, H. Rihova, D. Brezinova, and R. Dvorakova Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis? Leuk Res 28 2004 1013 1021
6. W. Zhang, M.A. Piatyszek, T. Kobayashi, E. Estey, M. Andreeff, and A.B. Deisseroth Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents Clin Cancer Res 2 1996 799 803
7. J.H. Ohyashiki, K. Ohyashiki, T. Fujimura, K. Kawakubo, T. Shimamoto, and A. Iwabuchi Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes Cancer Res 54 1994 3557 3560
8. J. Boultwood, C. Fidler, R. Kusec, K. Rack, P.J. Elliott, and O. Atoyebi Telomere length in myelodysplastic syndromes Am J Hematol 56 1997 266 271
9. K. Ohyashiki, H. Iwama, N. Yahata, T. Tauchi, K. Kawakubo, and T. Shimamoto Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation Leuk Lymphoma 42 2001 291 299
10. G.J. Mufti Pathobiology, classification, and diagnosis of myelodysplastic syndrome Best Pract Res Clin Haematol 17 2004 543 557
11. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumours: pathology and genetics of tumours of the haematopoietic and lymphoid tissues. Lyon: IARC; 2001.
12. P. Greenberg, C. Cox, M.M. Le Beau, P. Fenaux, P. Morel, and G. Sanz International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088
13. S. Bekaert, H. Derradji, and S. Baatout Telomere biology in mammalian germ cells and during development Dev Biol 274 2004 15 30
14. G. Sashida, J.H. Ohyashiki, A. Nakajima, M. Sumi, K. Kawakubo, and T. Tauchi Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases Clin Cancer Res 9 2003 1489 1496
15. M. Engelhardt, P. Drullinsky, J. Guillem, and M.A. Moore Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer Clin Cancer Res 3 1997 1931 1941
16. M. Engelhardt, J. Albanell, P. Drullinsky, W. Han, J. Guillem, and H.I. Scher Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma Clin Cancer Res 3 1997 1849 1857
17. M. Engelhardt, M.F. Ozkaynak, P. Drullinsky, C. Sandoval, O. Tugal, and S. Jayabose Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy Leukemia 12 1998 13 24
18. N. Elwood Telomere biology of human hematopoietic stem cells Cancer Control 11 2004 77 85
19. G.M. Rigolin, M.D. Porta, A.M. Bugli, B. Castagnari, E. Mauro, and L.Z. Bragotti Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings Eur J Haematol 73 2004 351 358
20. M. Engelhardt, K. Mackenzie, P. Drullinsky, R.T. Silver, and MA.S. Moore Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture Cancer Res 60 2000 610 617
21. M.A. Moore Expansion of myeloid stem cells in culture Semin Hematol 32 1995 183 200
22. M. Engelhardt, K. Mackenzie, and P. Drullinsky Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture Cancer Res 60 2000 610 617
23. K.F. Norrback, and G. Roos Telomeres and telomerase in normal and malignant haematopoietic cells Eur J Cancer 33 1997 774 780